Rankings
▼
Calendar
RCKT Q1 2025 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$572M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$64M
Net Income
-$61M
EPS (Diluted)
$-0.56
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$56M
Free Cash Flow
-$56M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$471M
Total Liabilities
$59M
Stockholders' Equity
$412M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$2M
+100.0%
Operating Income
-$64M
-$67M
+4.4%
Net Income
-$61M
-$62M
+1.2%
← FY 2025
All Quarters
Q2 2025 →